These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9949403)

  • 21. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
    Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
    Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The CT-stereotaxic neutron brachytherapy of brain tumors with californium sources on the ANET-B apparatus].
    Melikian AG; Liass FM; Shkol'nik FG; Chekhonadskiĭ VN; Elisiutin GP; Golanov AV; Kachkov IA; Borodkin SM; Lobanov SA; Spasokukotskaia ON
    Zh Vopr Neirokhir Im N N Burdenko; 1992; (2-3):15-21. PubMed ID: 1326193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Boron neutron capture enhancement of 252Cf brachytherapy.
    Beach JL; Schroy CB; Ashtari M; Harris MR; Maruyama Y
    Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1421-7. PubMed ID: 2370192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of augmentation of 252Cf implant by 10B and 157Gd neutron capture.
    Wierzbicki JG; Maruyama Y; Porter AT
    Med Phys; 1994 Jun; 21(6):787-90. PubMed ID: 7935215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shielding evaluation of a medical linear accelerator vault in preparation for installing a high-dose rate 252Cf remote afterloader.
    Melhus CS; Rivard MJ; Kurkomelis J; Liddle CB; Massé FX
    Radiat Prot Dosimetry; 2005; 113(4):428-37. PubMed ID: 15755770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dosimetry in interstitial radiotherapy using neutrons].
    Díez de los Ríos A; Martínez Morillo M
    Rev Esp Oncol; 1982; 29(2):301-6. PubMed ID: 7188231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of fission track detectors to californium-252 neutron dosimetry in tissue near the radiation source.
    Oswald RA; Lanzl LH; Rozenfeld M
    Med Phys; 1981; 8(3):292-301. PubMed ID: 7322053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase I trial of neutron brachytherapy for the treatment of malignant gliomas.
    Patchell RA; Yaes RJ; Beach L; Kryscio RJ; Davis DG; Tibbs PA; Young B
    Br J Radiol; 1997 Nov; 70(839):1162-8. PubMed ID: 9536908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of time-dose and fractionation for 252Cf neutrons in preoperative bulky/barrel-cervix carcinoma radiotherapy.
    Maruyama Y; Wierzbicki J
    Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1561-8. PubMed ID: 2262382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental and Monte Carlo determination of the TG-43 dosimetric parameters for the model 9011 THINSeed brachytherapy source.
    Kennedy RM; Davis SD; Micka JA; DeWerd LA
    Med Phys; 2010 Apr; 37(4):1681-8. PubMed ID: 20443489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric characteristics of a linear array of gamma or beta-emitting seeds in intravascular irradiation: Monte Carlo studies for the AAPM TG-43/60 formalism.
    Ye SJ; Parsai EI; Feldmeier JJ
    Med Phys; 2003 Mar; 30(3):403-14. PubMed ID: 12674241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources.
    Melhus CS; Rivard MJ
    Med Phys; 2006 Jun; 33(6):1729-37. PubMed ID: 16872080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutron and gamma dose distribution for tandem, tandem and ovoid and plaque for intracavitary 252Cf therapy of cervix carcinoma.
    Maruyama Y; Tai DL; Beach JL
    Radiat Med; 1983; 1(3):230-6. PubMed ID: 6390538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dosage fields of the "ANET-B" apparatus with 252Cf].
    Sevast'ianov AI; Drygin VN; Elisiutin GP; Karpova IA; Komar VIa
    Med Radiol (Mosk); 1983 May; 28(5):24-9. PubMed ID: 6855490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential of californium-252 in radiotherapy. Preclinical measurements in physics and radiobiology.
    Hall EJ; Rossi H
    Br J Radiol; 1975 Oct; 48(574):777-90. PubMed ID: 811295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical study of relative biological effectiveness for cervical carcinoma treated by 252Cf neutrons and assessed by histological tumour eradication.
    Maruyama Y; Feola JM; Wierzbicki J; van Nagell JR; Powell D; Yoneda J
    Br J Radiol; 1990 Apr; 63(748):270-7. PubMed ID: 2112036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AAPM TG-43 formalism for brachytherapy dose calculation of a 137Cs tube source.
    Zhang P; Beddar AS; Sibata CH
    Med Phys; 2004 Apr; 31(4):755-9. PubMed ID: 15124992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fast neutron dosimetry in 252Cf contact radiation therapy].
    Koval' GN; Nikishin BK; Isaenko VI; Abdullaev VD
    Med Radiol (Mosk); 1979 Jun; 24(6):63-7. PubMed ID: 459731
    [No Abstract]   [Full Text] [Related]  

  • 39. Response to "comment on 'experimental determination of the thermal neutron flux around two different types of high intensity 252Cf source'" [Med. Phys. 26, 2037-2038 (1999)].
    Schmidt R; Maughan RL; Yudelev M; Kota C; Wanwilairat S
    Med Phys; 1999 Sep; 26(9):2039-40. PubMed ID: 10505898
    [No Abstract]   [Full Text] [Related]  

  • 40. Comment on "Experimental determination of the thermal neutron flux around two different types of high intensity 252Cf source" [Med. Phys. 26, 83-86 (1999)].
    Rivard MJ
    Med Phys; 1999 Sep; 26(9):2037-8. PubMed ID: 10505897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.